BTK Inhibitors in Multiple Sclerosis Treatment - Part 1

Apr 24, 2025

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. 

Show reference:

https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 

https://www.nejm.org/doi/full/10.1056/NEJMoa2415988